sglt2 with glp 1 GLP1 Receptor Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Complementary Yet Distinct Roles of
Description
Soaring use of these medications for weight loss is shifting demand, including for packaging manufacturers that serve pharma and food customers
Genetically-predicted GLP1R expression (the target of GLP-1 RAs) showed an inverse association with background [odds ratio (OR)=0.83, 95% CI, 0.710.97] and severe nonproliferative DR (OR=0.72, 95% CI, 0.530.98), and a non-significant association with overall (OR=0.97, 95% CI, 0.921.03) and proliferative DR (OR=0.98, 95% CI, 0.911.05)
Note: it is a food supplement it does not contain or act like GLP-1 medication
Semaglutide, Wegovy, Zepbound & More
